1-3 of 3
Josée M Zijlstra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab-PECC Induction Followed by 90 y-Ibritumomab Tiuxetan Consolidation in Relapsed or Refractory DLBCL Patients Who Are Not Eligible for or After ASCT: Preliminary Results From a Phase II HOVON Study.

Free
Pieternella J Lugtenburg, MD, PhD, Josée M Zijlstra, MD, PhD, Jeanette K Doorduijn, Lara H Böhmer, MD, Marinus van Marwijk Kooy, MD, PhD, Mels Hoogendoorn, MD, PhD, Henriette W Berenschot, MD, PhD, Aart Beeker, MD, Fransje A Valster, MD, Harry C Schouten, MD, PhD, Marleen Luten, MSc, Dana A Chitu, Rolf E Brouwer, MD, PhD, Gustaaf W van Imhoff, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2729.
https://doi.org/10.1182/blood.V120.21.2729.2729
Published: 2012
Journal Articles

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma

Free
Clinical Trials & Observations
Bart W. Schot, Josée M. Zijlstra, Wim J. Sluiter, Gustaaf W. van Imhoff, Jan Pruim, Willem Vaalburg, Edo Vellenga
Journal: Blood
Blood (2006) 109 (2): 486–491.
https://doi.org/10.1182/blood-2005-11-006957
Published: 2006
Journal Articles

Systematic Review of 18 F-Fluorodeoxyglucose Positron Emission Tomography for Post-Treatment Evaluation of Malignant Lymphoma.

Free
Josée M. Zijlstra, MD, Otto S. Hoekstra, MD, PhD, Gerda Lindauer-van der Werf, MD, Lotty Hooft, MSc, PhD, Ingrid I. Riphagen, MSc, Peter C. Huijgens, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3340.
https://doi.org/10.1182/blood.V106.11.3340.3340
Published: 2005